News
Small Cap Stock news
-
Applied UV Announces Selected Preliminary Third Quarter 2023 Financial Results
[ad_1] · Total revenues for the third quarter of 2023 of approximately $11.4 million, representing an 94.8% increase over…
Read More » -
American Shared Hospital Services Reports Third Quarter 2023 Financial Results
[ad_1] – Sales Pipeline Continues to Increase, including 2 Existing Lease Extensions- – International Cancer Center Equipment Upgrades Advancing, Expect…
Read More » -
Artificial intelligence may speed heart attack diagnosis and treatment
[ad_1] Research Highlights: In a study of patients in a hospital in Taiwan, artificial intelligence technology paired with electrocardiogram…
Read More » -
New medication given every 1-3 months may slash stubborn high cholesterol
[ad_1] Research Highlights: While currently available PCSK9 inhibitor medications to lower cholesterol must be administered every few weeks by…
Read More » -
Martial Arts History Museum Moves to Glendale
[ad_1] (NewMediaWire) – November 12, 2023 – Burbank, CA – The Martial Arts History Museum, listed as one of the…
Read More » -
Anti-clotting pill reduced stroke risk in adults with symptomless, irregular heart rhythm
[ad_1] Research Highlights: In a large study of adults with implanted heart devices that detected short, symptomless bouts of…
Read More » -
Improving blood pressure control after pregnancy had long-term cardiovascular benefits
[ad_1] Research Highlights: Women with high blood pressure during pregnancy had lower blood pressure nine months later if their…
Read More » -
Single dose of zilebesiran safely and effectively lowered blood pressure for six months
[ad_1] Research Highlights: The phase 2 study found that a single injection of the experimental medication zilebesiran safely and effectively…
Read More » -
Reducing sodium intake significantly lowered blood pressure in as little as one week
[ad_1] Research Highlights: A randomized trial comparing the effects of high-sodium and low-sodium diets on blood pressure in adults with…
Read More » -
Major CVD event risk cut by 20% in adults without diabetes, with overweight or obesity
[ad_1] Research Highlights: In a large, international clinical trial, people with obesity or overweight but not diabetes taking semaglutide for…
Read More »
